Pfizer is making a bold move in the pharmaceutical world by closing in on a $7.3 billion deal to acquire Metsera, a biotech firm focused on next-generation anti-obesity drugs, news platform Financial Times reported on Monday.This acquisition underlines Pfizer’s fresh push into the booming weight-loss drug market, an area showing…
Indian IT stocks slumped on Monday after US President Donald Trump announced an overhaul of the H-1B visa programme,…
The United States has confirmed that a new $100,000 fee for H-1B visas will apply only to new applications,…
Abu Dhabi has opened its first Nvidia AI Technology Center in the Middle East, a joint initiative with the…
Europe’s markets opened weaker on Monday as investors balanced fresh corporate warnings with policy shocks from the United States.…
Shares of Adani Power Ltd surged 20% on Monday, September 22, after the stock began trading on an adjusted…
Snap stock price rose by over 6% in the pre-market session as investors cheered the Snap OS 2.0 and…
Ethereum has fallen sharply in the past 24 hours, sliding 7.08% to $4,152.70 as the second-largest cryptocurrency loses its…